Caliway Biopharmaceuticals (Caliway) announces that Australian Bellberry HREC has approved Caliway’s application to initiate CBL-514’s pivotal phase 3 study (CBL-0301 phase 3) for subcutaneous fat ...
Incannex Healthcare Limited, a clinical-stage pharmaceutical company, announced that it has received approval from Bellberry Human Research Ethics Committee (‘HREC’) for the lead site, Emeritus ...
Adze Biotech, develops systemically-deliverable oncolytic immunotherapies, received Bellberry HREC approval for Phase I clinical trial in metastatic melanoma. This approval validates the robustness of ...
The Bellberry application is a key regulatory milestone, advancing Adze's commitment to initiating clinical studies of its immunotherapy candidate, Adze1.C, Submitting the Bellberry HREC application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results